ATA Guidelines Tools

Adults with Differentiated THyroid Cancer - 2025 Update

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1540959

Contents of this Issue

Navigation

Page 41 of 49

Tables and Figures 42 Figure 5. DATA Framework for Initial Therapy Assessment 6–12 months after initial therapy for response classification: Tg/Tg Ab and Imaging Assessment 6–12 weeks post-op on levothyroxine therapy: Tg/Tg Ab and Imaging Treatment Decision: RAI therapy vs. no RAI therapy Histopathology ATA Risk of Recurrence Clinical Information AJCC Staging Diagnosis and Surgery DATA framework applied to the first 12 months aer DTC diagnosis. Imaging timing and type depend on risk of recurrence, Tg levels, and pathology/clinical factors.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Adults with Differentiated THyroid Cancer - 2025 Update